Literature DB >> 24492488

Possible Loss of GABAergic Inhibition in Mice With Induced Adenomyosis and Treatment With Epigallocatechin-3-Gallate Attenuates the Loss With Improved Hyperalgesia.

Yumei Chen1, Bo Zhu1, Hongping Zhang1, Ding Ding2, Xishi Liu2, Sun-Wei Guo3.   

Abstract

We have previously reported that induction of adenomyosis in mice results in progressive hyperalgesia, uterine hyperactivity, and elevated plasma corticosterone levels and that epigallocatechin-3-gallate (EGCG) treatment dose dependently suppressed myometrial infiltration and improved generalized hyperalgesia. In this study, we examined whether adenomyosis induced in mice results in the loss of GABAergic inhibition as manifested by the diminished glutamate decarboxylase (GAD) 65-expressing neurons in the brainstem nucleus raphe magnus (NRM) that could correlate with heightened hyperalgesia. We also evaluated whether EGCG treatment would reverse these changes and also improve the expression of some proteins known to be involved in adenomyosis. Adenomyosis was induced in 28 female ICR mice and additional 12 were used as blank controls, as reported previously. At the 16th week, all mice with induced adenomyosis received low- or high-dose EGCG treatment or untreated. Mice without adenomyosis received no treatment. After 3 weeks of treatment, their uterine horns and brains were harvested. The right uterine horn was used for immunohistochemistry analysis and for counting the number of macrophages infiltrating into the ectopic endometrium. The brainstem NRM sections were subjected to immunofluorescence staining for GAD65. We found that mice with induced adenomyosis had significantly diminished GAD65-expressing neurons, concomitant with heightened hyperalgesia. Treatment with EGCG increased these neurons in conjunction with improved hyperalgesia, reduced the expression of p-p65, cycloxygenase 2, oxytocin receptor, collagen I and IV, and transient receptor potential vanilloid type 1 in ectopic endometrium or myometrium, reduced the number of macrophages infiltrating into the ectopic endometrium while elevated the expression of progesterone receptor isoform B. Thus, adenomyosis-induced pain resembles neuropathic pain in that there is a remarkable central plasticity.
© The Author(s) 2013.

Entities:  

Keywords:  GABAergic inhibition; adenomyosis; epigallocatechin-3-gallate; hyperalgesia; mouse; pain; treatment

Year:  2014        PMID: 24492488      PMCID: PMC4107564          DOI: 10.1177/1933719113518984

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  74 in total

1.  Extracellular matrix-dependent regulation of Fas ligand expression in human endometrial stromal cells.

Authors:  Belgin Selam; Umit A Kayisli; Juan A Garcia-Velasco; Aydin Arici
Journal:  Biol Reprod       Date:  2002-01       Impact factor: 4.285

2.  Oestrogen-induced epithelial-mesenchymal transition of endometrial epithelial cells contributes to the development of adenomyosis.

Authors:  Yi-Jen Chen; Hsin-Yang Li; Chi-Hung Huang; Nae-Fang Twu; Ming-Shyen Yen; Peng-Hui Wang; Teh-Ying Chou; Yen-Ni Liu; Kuan-Chong Chao; Muh-Hwa Yang
Journal:  J Pathol       Date:  2010-11       Impact factor: 7.996

3.  Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis.

Authors:  Xishi Liu; Sun-Wei Guo
Journal:  J Obstet Gynaecol Res       Date:  2011-06-09       Impact factor: 1.730

4.  Spinal GABA(A) and GABA(B) receptor pharmacology in a rat model of neuropathic pain.

Authors:  T Philip Malan; Heriberto P Mata; Frank Porreca
Journal:  Anesthesiology       Date:  2002-05       Impact factor: 7.892

Review 5.  The molecular dynamics of pain control.

Authors:  S P Hunt; P W Mantyh
Journal:  Nat Rev Neurosci       Date:  2001-02       Impact factor: 34.870

6.  Dysmenorrhea and its severity are associated with increased uterine contractility and overexpression of oxytocin receptor (OTR) in women with symptomatic adenomyosis.

Authors:  Sun-Wei Guo; Xiaoyan Mao; Qingliang Ma; Xishi Liu
Journal:  Fertil Steril       Date:  2012-09-19       Impact factor: 7.329

7.  Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.

Authors:  Ming Zhu Fang; Yimin Wang; Ni Ai; Zhe Hou; Yi Sun; Hong Lu; William Welsh; Chung S Yang
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

Review 8.  Chronic pain and medullary descending facilitation.

Authors:  Frank Porreca; Michael H Ossipov; G F Gebhart
Journal:  Trends Neurosci       Date:  2002-06       Impact factor: 13.837

9.  Abnormal cerebral metabolism during menstrual pain in primary dysmenorrhea.

Authors:  Cheng-Hao Tu; David M Niddam; Hsiang-Tai Chao; Ren-Shyan Liu; Ren-Jen Hwang; Tzu-Chen Yeh; Jen-Chuen Hsieh
Journal:  Neuroimage       Date:  2009-04-09       Impact factor: 6.556

10.  (-)-Epigallocatechin 3-gallate inhibits invasion by inducing the expression of Raf kinase inhibitor protein in AsPC‑1 human pancreatic adenocarcinoma cells through the modulation of histone deacetylase activity.

Authors:  Sung Ok Kim; Mi Ryeo Kim
Journal:  Int J Oncol       Date:  2012-11-06       Impact factor: 5.650

View more
  5 in total

1.  Animal Models of Adenomyosis.

Authors:  Ryan M Marquardt; Jae-Wook Jeong; Asgerally T Fazleabas
Journal:  Semin Reprod Med       Date:  2020-10-26       Impact factor: 1.303

2.  Anti-platelet therapy holds promises in treating adenomyosis: experimental evidence.

Authors:  Bo Zhu; Yumei Chen; Xiaolu Shen; Xishi Liu; Sun-Wei Guo
Journal:  Reprod Biol Endocrinol       Date:  2016-10-10       Impact factor: 5.211

Review 3.  The roles of epigallocatechin-3-gallate in the treatment of neuropathic pain: an update on preclinical in vivo studies and future perspectives.

Authors:  Sabrina Bimonte; Marco Cascella; Vincenzo Schiavone; Farrokh Mehrabi-Kermani; Arturo Cuomo
Journal:  Drug Des Devel Ther       Date:  2017-09-13       Impact factor: 4.162

4.  The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea.

Authors:  Xuan Che; Jianzhang Wang; Jiayi He; Xinyue Guo; Tiantian Li; Xinmei Zhang
Journal:  Int J Med Sci       Date:  2020-01-14       Impact factor: 3.738

5.  Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis.

Authors:  Xiaofang Xu; Xianjun Cai; Sun-Wei Guo; Xishi Liu
Journal:  Reprod Biol Endocrinol       Date:  2021-02-19       Impact factor: 5.211

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.